Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2021-06-25 AGM Information
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
AGM Information Classification · 95% confidence The document is a press release announcing the results of the Annual General Meeting (AGM) of Avicanna Inc. It details the election of directors, voting results, appointment of auditors, introduction of new board members, and provides a corporate update. The focus is on the AGM outcomes and corporate progress rather than the full annual report or financial statements. The document is not a full Annual Report (10-K) or an Interim Report (IR), nor is it a Proxy Solicitation or Voting Results declaration alone. It is a communication about the AGM results and corporate updates, fitting the category of AGM Information (AGM-R). The document length (12,856 characters) and content support this classification with high confidence.
2021-06-25 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the expansion of product offerings by Avicanna Inc., specifically new THC-free high CBD oral and sublingual formulations. It contains marketing and product information, market opportunity discussion, company background, and forward-looking statements. There are no financial statements, regulatory filings, voting results, or management changes. The document is a corporate news announcement about product development and market strategy, not a financial report, regulatory filing, or meeting material. Therefore, it fits best into the category of a general Regulatory Filing (RNS) as a miscellaneous corporate announcement that does not fit other specific categories.
2021-06-15 English
News release - English.pdf
Regulatory Filings Classification · 100% confidence The document is an announcement by Avicanna Inc. regarding a Cease Trade Order issued by the Ontario Securities Commission due to the company's failure to file certain periodic disclosure documents by the required deadline. It lists the specific documents not filed, including audited annual financial statements, management's discussion and analysis, annual information form, interim financial statements, and certifications. The document does not contain the actual financial statements or detailed financial data but rather informs about the regulatory action and the company's plan to file the documents later. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about compliance issues and not the actual financial reports themselves.
2021-06-12 English
News release - English.pdf
Regulatory Filings Classification · 100% confidence The document text contains only a placeholder message indicating that the PDF viewer cannot display the document content. There is no substantive content related to any financial report, announcement, or filing. Therefore, it does not fit any specific filing category and should be classified as a Regulatory Filing (RNS) as a fallback for miscellaneous or non-informative filings.
2021-06-08 English
News release - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an announcement from Avicanna Inc. regarding the mailing of its Management Information Circular and proposed changes to the Board of Directors ahead of its Annual General Meeting (AGM). It details the virtual format of the meeting, proxy voting instructions, and introduces new board nominees while thanking outgoing members. The document does not contain the actual Management Information Circular or detailed financial data but rather announces the mailing and contents related to the AGM. This fits the category of Proxy Solicitation & Information Statement (PSI), as it is proxy-related material sent to shareholders to provide information and request votes for the meeting. It is not the AGM presentation itself, nor an annual report or management report. Therefore, the correct classification is PSI with high confidence.
2021-06-03 English
Management information circular - English.pdf
AGM Information Classification · 100% confidence The document is titled as a "NOTICE OF ANNUAL MEETING OF SHAREHOLDERS" and includes a "MANAGEMENT INFORMATION CIRCULAR" for the annual general meeting (AGM) of Avicanna Inc. It details the date and time of the AGM, voting procedures, proxy solicitation, and other meeting logistics. The content focuses on informing shareholders about the meeting, how to vote, and proxy appointments. There are no financial statements, audit results, or earnings data presented. The document is lengthy (15,000 characters) but is clearly a notice and circular related to the AGM, not the actual annual report or financial filings. Therefore, it fits the category of AGM Information (AGM-R).
2021-06-03 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.